TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01670071

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Cause of deathSlow enrollment, also regulatory or ethics Automatic label, confidence 0.5, unverified. How labels are made.
“The study was terminated due to insufficient sample size and protocol compliance issue.”

The sponsor’s own words in the registry.

Life of this trial

20122013201420152016Registered2012-08-17Started2013-01Stopped2015-06

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Johnson & Johnson Taiwan Ltd
Sponsor type
Industry
Conditions
Schizophrenia
Interventions
Paliperidone extended-release; Risperidone immediate-release
Participants
17
Sites
3
Countries
Taiwan

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.